Baeocystin
| 4-PO-NMT | |
|---|---|
| Molecular structure via molpic based on CDK |
| Physical properties [] | |
|---|---|
| Molecular mass | 270.22 g/mol [1] |
| Predicted LogP | -2.1 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C11H15N2O4P [1] |
| IUPAC name | [3-[2-(methylamino)ethyl]-1H-indol-4-yl] dihydrogen phosphate [1] |
| SMILES | CNCCC1=CNC2=C1C(=CC=C2)OP(=O)(O)O [1] |
| InChI | InChI=1S/C11H15N2O4P/c1-12-6-5-8-7-13-9-3-2-4-10(11(8)9)17-18(14,15)16/h2-4,7,12-13H,5-6H2,1H3,(H2,14,15,16) [1] |
| InChIKey | WTPBXXCVZZZXKR-UHFFFAOYSA-N [1] |
Baeocystin (also known as Baeocystin, 4-hydroxy-N-methyltryptamine 4-phosphate, Chebi:139505, Dtxsid70175693, 1H-Indol-4-ol, 3-(2-(methylamino)ethyl)-, dihydrogen phosphate, (3-(2-(methylamino)ethyl)-1H-indol-4-yl) dihydrogen phosphate, Dtxcid0098184, 3-[2-(methylamino)ethyl]-1h-indol-4-yl dihydrogen phosphate, Beocystin or [3-(2-methylaminoethyl)-1H-indol-4-yl] dihydrogen phosphate) is a prodrug substance of the tryptamine class.
Chemistry
Stereochemistry []
Baeocystin is a achiral mixture.
Legal status []
- United Kingdom: Baeocystin is a Class A substance.
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 161359, Baeocystin. Accessed April 29, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/161359
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Baeocystin. UNII: 22KW205WF2. Global Substance Registration System. Accessed April 29, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/22KW205WF2